Agenus Capex To Revenue vs Ebit Per Revenue Analysis

AGEN Stock

USD 3.55 0.21 6.29%

Agenus financial indicator trend analysis is way more than just evaluating Agenus Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Agenus Inc is a good investment. Please check the relationship between Agenus Capex To Revenue and its Ebit Per Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Capex To Revenue vs Ebit Per Revenue

Capex To Revenue vs Ebit Per Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Agenus Inc Capex To Revenue account and Ebit Per Revenue. At this time, the significance of the direction appears to have pay attention.

The correlation between Agenus' Capex To Revenue and Ebit Per Revenue is -0.99. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Ebit Per Revenue in the same time period over historical financial statements of Agenus Inc, assuming nothing else is changed. The correlation between historical values of Agenus' Capex To Revenue and Ebit Per Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Agenus Inc are associated (or correlated) with its Ebit Per Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit Per Revenue has no effect on the direction of Capex To Revenue i.e., Agenus' Capex To Revenue and Ebit Per Revenue go up and down completely randomly.

Correlation Coefficient

-0.99

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Ebit Per Revenue

Most indicators from Agenus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Agenus Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

At this time, Agenus' Selling General Administrative is very stable compared to the past year. As of the 25th of November 2024, Issuance Of Capital Stock is likely to grow to about 136.4 M, while Sales General And Administrative To Revenue is likely to drop 0.48.

Agenus fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Other Assets	Long Term Debt
Total Assets		0.49	0.78	0.81	-0.16	0.83	-0.05	-0.8	0.78	0.85	0.88	0.85	0.86	-0.21	0.84	0.7	0.59	0.62	0.84	0.83	0.89	0.39	-0.21	0.72	0.24	-0.08
Short Long Term Debt Total	0.49		0.02	0.74	-0.33	0.73	0.83	-0.65	0.81	0.07	0.75	0.33	0.08	-0.19	0.77	0.14	0.89	0.38	0.55	0.73	0.13	0.93	-0.18	0.39	-0.12	0.17
Other Current Liab	0.78	0.02		0.61	-0.39	0.59	-0.38	-0.7	0.48	0.71	0.64	0.7	0.72	-0.24	0.59	0.9	0.19	0.7	0.81	0.56	0.76	-0.04	-0.24	0.77	0.44	-0.22
Total Current Liabilities	0.81	0.74	0.61		-0.57	0.96	0.42	-0.94	0.97	0.4	0.96	0.7	0.42	-0.22	0.99	0.6	0.88	0.65	0.92	0.94	0.48	0.76	-0.21	0.87	0.25	-0.28
Total Stockholder Equity	-0.16	-0.33	-0.39	-0.57		-0.39	-0.41	0.64	-0.46	0.22	-0.44	-0.1	0.21	0.31	-0.5	-0.6	-0.41	-0.58	-0.66	-0.32	0.13	-0.4	0.31	-0.71	-0.27	0.21
Property Plant And Equipment Net	0.83	0.73	0.59	0.96	-0.39		0.4	-0.88	0.97	0.43	0.98	0.68	0.45	-0.16	0.97	0.49	0.87	0.57	0.84	0.99	0.5	0.73	-0.15	0.75	0.2	-0.28
Net Debt	-0.05	0.83	-0.38	0.42	-0.41	0.4		-0.32	0.51	-0.5	0.37	-0.15	-0.49	-0.1	0.42	-0.2	0.69	0.11	0.18	0.38	-0.44	0.85	-0.09	0.1	-0.24	0.13
Retained Earnings	-0.8	-0.65	-0.7	-0.94	0.64	-0.88	-0.32		-0.89	-0.43	-0.93	-0.7	-0.45	0.49	-0.94	-0.75	-0.74	-0.84	-0.96	-0.85	-0.52	-0.62	0.49	-0.88	-0.23	0.16
Accounts Payable	0.78	0.81	0.48	0.97	-0.46	0.97	0.51	-0.89		0.35	0.95	0.66	0.37	-0.17	0.98	0.45	0.94	0.56	0.83	0.97	0.42	0.84	-0.17	0.78	0.15	-0.29
Cash	0.85	0.07	0.71	0.4	0.22	0.43	-0.5	-0.43	0.35		0.5	0.78	1.0	-0.12	0.44	0.59	0.14	0.41	0.53	0.45	0.99	-0.07	-0.12	0.42	0.24	0.05
Non Current Assets Total	0.88	0.75	0.64	0.96	-0.44	0.98	0.37	-0.93	0.95	0.5		0.69	0.52	-0.24	0.98	0.61	0.83	0.67	0.9	0.96	0.57	0.7	-0.24	0.78	0.16	-0.13
Non Currrent Assets Other	0.85	0.33	0.7	0.7	-0.1	0.68	-0.15	-0.7	0.66	0.78	0.69		0.79	-0.22	0.71	0.57	0.51	0.58	0.69	0.71	0.81	0.33	-0.22	0.66	0.38	-0.28
Cash And Short Term Investments	0.86	0.08	0.72	0.42	0.21	0.45	-0.49	-0.45	0.37	1.0	0.52	0.79		-0.12	0.46	0.58	0.16	0.41	0.54	0.48	0.99	-0.05	-0.12	0.44	0.24	0.03
Common Stock Total Equity	-0.21	-0.19	-0.24	-0.22	0.31	-0.16	-0.1	0.49	-0.17	-0.12	-0.24	-0.22	-0.12		-0.26	-0.37	-0.06	-0.67	-0.33	-0.14	-0.15	-0.08	1.0	-0.26	0.13	-0.21
Common Stock Shares Outstanding	0.84	0.77	0.59	0.99	-0.5	0.97	0.42	-0.94	0.98	0.44	0.98	0.71	0.46	-0.26		0.58	0.89	0.66	0.9	0.96	0.51	0.77	-0.26	0.83	0.2	-0.23
Non Current Liabilities Total	0.7	0.14	0.9	0.6	-0.6	0.49	-0.2	-0.75	0.45	0.59	0.61	0.57	0.58	-0.37	0.58		0.21	0.83	0.85	0.45	0.65	0.04	-0.37	0.79	0.36	0.0
Other Current Assets	0.59	0.89	0.19	0.88	-0.41	0.87	0.69	-0.74	0.94	0.14	0.83	0.51	0.16	-0.06	0.89	0.21		0.38	0.66	0.87	0.21	0.96	-0.05	0.63	0.11	-0.28
Other Stockholder Equity	0.62	0.38	0.7	0.65	-0.58	0.57	0.11	-0.84	0.56	0.41	0.67	0.58	0.41	-0.67	0.66	0.83	0.38		0.78	0.54	0.48	0.29	-0.67	0.69	0.19	0.05
Total Liab	0.84	0.55	0.81	0.92	-0.66	0.84	0.18	-0.96	0.83	0.53	0.9	0.69	0.54	-0.33	0.9	0.85	0.66	0.78		0.8	0.61	0.51	-0.32	0.94	0.33	-0.16
Property Plant And Equipment Gross	0.83	0.73	0.56	0.94	-0.32	0.99	0.38	-0.85	0.97	0.45	0.96	0.71	0.48	-0.14	0.96	0.45	0.87	0.54	0.8		0.52	0.74	-0.14	0.72	0.17	-0.29
Total Current Assets	0.89	0.13	0.76	0.48	0.13	0.5	-0.44	-0.52	0.42	0.99	0.57	0.81	0.99	-0.15	0.51	0.65	0.21	0.48	0.61	0.52		0.0	-0.15	0.5	0.23	0.03
Short Term Debt	0.39	0.93	-0.04	0.76	-0.4	0.73	0.85	-0.62	0.84	-0.07	0.7	0.33	-0.05	-0.08	0.77	0.04	0.96	0.29	0.51	0.74	0.0		-0.08	0.47	-0.04	-0.16
Common Stock	-0.21	-0.18	-0.24	-0.21	0.31	-0.15	-0.09	0.49	-0.17	-0.12	-0.24	-0.22	-0.12	1.0	-0.26	-0.37	-0.05	-0.67	-0.32	-0.14	-0.15	-0.08		-0.25	0.13	-0.22
Other Liab	0.72	0.39	0.77	0.87	-0.71	0.75	0.1	-0.88	0.78	0.42	0.78	0.66	0.44	-0.26	0.83	0.79	0.63	0.69	0.94	0.72	0.5	0.47	-0.25		0.44	-0.46
Other Assets	0.24	-0.12	0.44	0.25	-0.27	0.2	-0.24	-0.23	0.15	0.24	0.16	0.38	0.24	0.13	0.2	0.36	0.11	0.19	0.33	0.17	0.23	-0.04	0.13	0.44		-0.43
Long Term Debt	-0.08	0.17	-0.22	-0.28	0.21	-0.28	0.13	0.16	-0.29	0.05	-0.13	-0.28	0.03	-0.21	-0.23	0.0	-0.28	0.05	-0.16	-0.29	0.03	-0.16	-0.22	-0.46	-0.43

Click cells to compare fundamentals

Agenus Account Relationship Matchups

Agenus fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	155.3M	214.5M	466.0M	413.6M	313.9M	329.6M
Short Long Term Debt Total	23.4M	55.7M	58.3M	78.4M	350.2M	367.8M
Other Current Liab	77.5M	92.9M	110.7M	133.2M	48.7M	28.4M
Total Current Liabilities	122.2M	129.9M	156.9M	189.0M	255.9M	268.7M
Total Stockholder Equity	(225.4M)	(203.7M)	34.4M	(61.3M)	(160.3M)	(152.3M)
Property Plant And Equipment Net	33.7M	60.3M	91.1M	164.3M	163.0M	171.2M
Net Debt	(38.4M)	(44.1M)	(233.6M)	(100.2M)	274.1M	287.8M
Retained Earnings	(1.3B)	(1.5B)	(1.5B)	(1.7B)	(2.0B)	(1.9B)
Accounts Payable	13.6M	17.0M	30.5M	40.9M	61.4M	64.5M
Cash	61.8M	99.9M	291.9M	178.7M	76.1M	71.1M
Non Current Assets Total	68.8M	100.7M	134.0M	200.4M	201.5M	211.6M
Non Currrent Assets Other	1.4M	4.1M	9.5M	4.5M	5.7M	3.5M
Cash And Short Term Investments	61.8M	99.9M	306.9M	193.4M	76.1M	81.2M
Common Stock Total Equity	1.4M	2.0M	2.6M	3.1M	2.8M	3.7M
Common Stock Shares Outstanding	6.7M	8.6M	11.4M	14.1M	17.9M	18.8M
Liabilities And Stockholders Equity	155.3M	214.5M	466.0M	413.6M	313.9M	329.6M
Non Current Liabilities Total	264.5M	296.1M	261.1M	279.5M	206.4M	113.2M
Other Current Assets	1.0M	2.0M	3.2M	3.2M	10.5M	11.0M
Other Stockholder Equity	1.0B	1.2B	1.1B	1.2B	1.5B	745.1M
Total Liab	386.7M	426.0M	418.0M	468.5M	462.3M	485.4M
Property Plant And Equipment Gross	26.3M	60.3M	141.6M	218.4M	225.0M	236.2M
Total Current Assets	86.5M	113.8M	332.0M	213.1M	112.4M	91.0M
Accumulated Other Comprehensive Income	(1.3M)	2.8M	1.5M	915K	(955K)	(1.0M)
Short Term Debt	2.0M	2.8M	3.4M	2.5M	145.7M	153.0M
Common Stock	1.4M	2.0M	2.6M	3.1M	3.9M	3.7M
Other Liab	216.1M	216.2M	205.9M	191.3M	220.0M	231.0M
Other Assets	1.4M	37.6M	9.5M	4.5M	4.0M	3.1M
Long Term Debt	13.4M	18.9M	12.8M	12.6M	12.8M	12.1M
Net Receivables	16.3M	1.2M	1.5M	2.7M	25.8M	27.1M
Good Will	23.2M	25.5M	24.9M	25.5M	24.7M	23.5M
Inventory	7.4M	10.7M	20.4M	13.8M	1.0	0.95
Intangible Assets	10.5M	10.9M	8.5M	6.2M	4.4M	8.2M
Property Plant Equipment	26.3M	60.3M	91.1M	133.0M	153.0M	160.6M
Current Deferred Revenue	29.2M	17.2M	12.4M	12.3M	18K	17.1K
Net Tangible Assets	(21.0M)	(240.0M)	1.1M	159.2M	183.1M	192.3M
Noncontrolling Interest In Consolidated Entity	(6.0M)	(7.8M)	13.5M	6.4M	7.3M	7.7M
Retained Earnings Total Equity	(1.3B)	(1.5B)	(1.5B)	(1.7B)	(1.5B)	(1.6B)
Long Term Debt Total	13.4M	18.9M	12.8M	12.6M	11.3M	10.8M

Pair Trading with Agenus

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agenus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will appreciate offsetting losses from the drop in the long position's value.

Moving together with Agenus Stock

0.86	ME	23Andme Holding	Pair Corr
0.76	VALN	Valneva SE ADR	Pair Corr
0.85	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr

Moving against Agenus Stock

0.59	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.54	KZR	Kezar Life Sciences	Pair Corr
0.37	RNXT	RenovoRx	Pair Corr
0.34	MLYS	Mineralys Therapeutics,	Pair Corr

The ability to find closely correlated positions to Agenus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agenus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agenus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agenus Inc to buy it.

The correlation of Agenus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Agenus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:

How To Invest In Agenus

Details

Is Agenus Stock a good investment?

Details

What is Agenus' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(11.02)

Revenue Per Share

7.808

Quarterly Revenue Growth

0.033

Return On Assets

(0.22)

Return On Equity

(12.79)

The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Agenus Capex To Revenue vs Ebit Per Revenue Analysis

Capex To Revenue vs Ebit Per Revenue

Capex To Revenue vs Ebit Per Revenue Correlation Analysis

Correlation Coefficient

Capex To Revenue

Ebit Per Revenue

Agenus fundamental ratios Correlations

Agenus Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Agenus fundamental ratios Accounts

Pair Trading with Agenus

Moving together with Agenus Stock

Moving against Agenus Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Common Stock Shares Outstanding	+ 0.99	Total Current Liabilities
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments

Total Liab	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Retained Earnings	- 0.94	Total Current Liabilities
Non Current Assets Total	- 0.93	Retained Earnings
Accounts Payable	- 0.89	Retained Earnings
Other Liab	- 0.88	Retained Earnings